Home | NRI | Business Associates | Knowledge Bank | Careers | Back Office | Contact Us
 

Get Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss Accounts
Quarterly Results
Key Financial Ratios
Share Price
Charts
 
 
Quarterly Results
Lupin Ltd
    Industry   : Pharmaceuticals - Indian - Bulk Drugs & Formln  Chairman  : M D Gupta
    Home        : Indian Private  Book Value: 422.9660038
    BSE Code  : 500257  Market Cap: 74991.4
    NSE Code  : LUPIN  P / E              : 36.39 

Change Company :
   Quarters: 
(Rs in Cr.)
Quarterly Results
ParticularsDec 2023Sep 2023Jun 2023Mar 2023
Type3Qtr2Qtr1Qtr4Qtr
Net Sales3999.473560.233425.012744.56
Other Income23.1625.6027.7455.30
Total Income4138.913684.833523.382891.57
Total Expenditure 2898.412823.992790.622574.09
Operating Profit1240.50860.84732.76317.48
Interest11.3615.3216.1829.44
Gross Profit1229.14845.52716.58288.04
Depreciation145.18149.48140.05146.20
Tax184.61129.66100.7225.42
Deferred Tax-17.0917.77-1.15-2.59
Reported Profit After Tax916.44548.61476.96119.01
BSE Disclaimer     |     Disclaimer     |     Privacy Statement     |     Terms of Use     |     Feedback     |    Sitemap     |    Downloads    |     Client Bank Details
Useful Links   |   Risk Disclosure   |   Rules and Regulations   |   Investor Charter   |   Investor Complaints   |   Smart ODR   |   Attention Investors  
SSJ FINANCE & SECURITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822
SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481
2006-07 © SSJ Finance & Securities Pvt. Ltd. All Rights Reserved    Developed & Maintained By C-MOTS Infotech(ISO 9001:2015 certified) Content powered by Capital Market